These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2472530)

  • 1. Intravenous dilevalol in the treatment of severe hypertension.
    Bursztyn M; Gavras I; Blasucci DJ; Gavras H
    J Cardiovasc Pharmacol; 1989 May; 13(5):799-802. PubMed ID: 2472530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing.
    Wallin JD; Cook ME; Fletcher E; Holtzman JL; Winer N; Gavras H; Grim CE; Ramanathan KB; Vidt DG; Johnson BF
    Arch Intern Med; 1989 Dec; 149(12):2655-61. PubMed ID: 2688585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological evaluation of dilevalol vasodilating properties in mild to moderate hypertension.
    Drici MD; Candito M; Ferrari E; Jacomet Y; Morand P; Lapalus P
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):361-5. PubMed ID: 1937998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labetalol in resistant hypertension.
    Dargie HJ; Dollery CT; Daniel J
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazoxide vs labetalol: a cross-over comparison of short-term effects in hypertension.
    Rumboldt Z; Bagatin J; Vidovic A
    Int J Clin Pharmacol Res; 1983; 3(1):47-54. PubMed ID: 6679507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of once-daily dilevalol in patients with mild hypertension: a placebo-controlled study.
    Soberman J; Greenberg S; Frishman W
    J Clin Hypertens; 1987 Sep; 3(3):271-7. PubMed ID: 3312501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dilevalol in hypertension assessed by digital pulse plethysmography.
    Takemiya T; Shimizu M; Yamaguti S; Sugishita H; Miuria Y; Yamauti T
    Clin Ther; 1992; 14(3):385-9. PubMed ID: 1638579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of clinical trials of dilevalol in essential hypertension.
    Glover DR; Tarbit WJ
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():49-53. PubMed ID: 2142508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH
    Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of labetalol in the treatment of hypertensive crises].
    Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
    G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the efficacy and safety of dilevalol in the treatment of essential arterial hypertension].
    Bochicchio T; Pérez-Grovas HA; Carrizosa J; Herrera-Acosta J
    Arch Inst Cardiol Mex; 1989; 59(2):181-6. PubMed ID: 2569857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dilevalol and propranolol on hemodynamics in patients with essential hypertension.
    Hama J; Oda A; Hirano Y; Horiuchi M; Katori R
    Clin Ther; 1991; 13(4):467-70. PubMed ID: 1933998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous dilevalol. Effects of the R-R optical isomer of labetalol in patients with severe hypertension.
    Wallin JD; Cook ME; Clifton GG; Blasucci DJ; Poland M
    Arch Intern Med; 1988 Mar; 148(3):534-8. PubMed ID: 3277568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982; 12(10):729-35. PubMed ID: 7182212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter comparison of dilevalol to placebo in patients with mild hypertension.
    Frishman WH; Schoenberger JA; Gorwit JI; Bedsole GD; Cubbon J; Poland MP
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):295S-299S. PubMed ID: 3046631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-ranging study of labetalol in moderate to moderately severe hypertension.
    Darmansjah I; Setiawati A; Prabowo P; Sukandar E; Parsoedi I; Ardaya ; Bahry B; Jusman J; Anggraeni E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):226-31. PubMed ID: 7620693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
    Schoenberger JA; Wallin JD; Gorwit JI; Davidov ME; Michelson EL; Poland MP; Frishman WH
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.